Phase II Study of Cabozantinib in Patients With Gastrointestinal Stromal Tumor (GIST) Who Progressed During Neoadjuvant, Adjuvant or Palliative Therapy With Imatinib and Sunitinib
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Cabozantinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 24 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Aug 2019.
- 24 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2019.
- 24 Mar 2017 Status changed from not yet recruiting to recruiting.